Gå direkt till huvudinnehållet

Sexuell upphetsningsstörning

Senast uppdaterad: Publicerad:
Sakkunnig:
  1. Frank JE, Mistretta P. Diagnosis and treatment of female sexual dysfunction. Am Fam Physician 2008; 77: 635-42. American Family Physician  
  2. Basson R. Sexual desire and arousal disorders in women. N Engl J Med 2006; 354: 1497-1506. PubMed  
  3. Hartmann U, Philippsohn S, Heiser K, Rüffer-Hesse C. Low sexual desire in midlife and older women: personality factors, psychosocial development, present sexuality. Menopause 2004; 11: 726-40. PubMed  
  4. Buster JE, Kingsberg SA, Aguirre O, et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 2005; 105: 944-52. PubMed  
  5. Braunstein G, Sundwall DA, Katz M, et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 2005; 165: 1582-9. PubMed  
  6. Basson R, Althof S, Davis S, et al. Summary of the recommendations on sexual dysfunctions in women. J Sex Med 2004; 1: 24-34. PubMed  
  7. Simons JS, Carey MP. Prevalence of sexual dysfunctions: results from a decade of research. Arch Sex Behav 2001; 30: 177-219. PubMed  
  8. Sexual and gender identity disorders. In: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000: 493-538.
  9. Mercer CH, Fenton KA, Johnson AM, et al. Sexual function problems and help seeking behaviour in Britain: national probability sample survey. BMJ 2003; 327: 426-7. British Medical Journal  
  10. Laumann EO, Nicolosi A, Glasser DB, et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005; 17: 39-57. PubMed  
  11. Oberg K, Fugl-Meyer AR, Fugl-Meyer KS. On categorization and quantification of women's sexual dysfunctions: an epidemiological approach. Int J Impot Res. 2004 ; Jun;16(3):: 261-9. doi:PMID: 15184916 PubMed  
  12. Caine VS, Johannes CB, Avis NE, et al. Sexual functioning and practices in a multi-ethnic study of midlife woman: baseline results from SWAN. J Sex Res 2003; 40: 266-76. PubMed  
  13. Avis NE, Zhao X, Johannes CB, Ory M, Brockwell S, Greendale GA. Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women's Health Across the Nation (SWAN). Menopause 2005; 12: 385-98. PubMed  
  14. Bancroft J, Loftus J, Long JS. Distress about sex: a national survey of women in heterosexual relationships. Arch Sex Behav 2003; 32: 193-211. PubMed  
  15. van Lunsen RHW, Laan E. Genital vascular responsiveness in sexual feelings in midlife women: psychophysiologic, brain, and genital imaging studies. Menopause 2004; 11: 741-8. PubMed  
  16. Maravilla KR, Heiman JR, Garland PA, et al. Dynamic MR imaging of the sexual arousal response in women. J Sex Marital Ther 2003; 29(Suppl 1): 71-76.
  17. Segraves RT, Clayton A, Croft H, Wolf A, Warnock J. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol 2004; 24: 339-42. PubMed  
  18. Santoro A, Torrens J, Crawford S, et al. Correlates of circulating androgens in mid-life women: the Study of Women's Health Across the Nation. J Clin Endocrinol Metab 2005; 90: 4836-45. PubMed  
  19. Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels in self-reported sexual function in women. JAMA 2005; 294: 91-6. Journal of the American Medical Association  
  20. Labrie F, Luu-The V, Belanger A, et al. Is dehydroepiandrosterone a hormone? J Endocrinol 2005; 187: 169-96. PubMed  
  21. Clayton AH, Pradko JF, Croft HA, et al. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002; 63: 357-66. PubMed  
  22. Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception 2001; 64: 51-8. PubMed  
  23. Panzer C, Wise S, Fantini G, et al. Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction. J Sex Med 2006; 3: 104-13. PubMed  
  24. Dennerstein L, Lehert P. Modeling mid-aged women's sexual functioning: a prospective, population-based study. J Sex Marital Ther 2005; 30: 173-83. PubMed  
  25. Verhaak CM, Smeenk JMJ, van Minnen A, Kremer JAM, Kraaimaat FW. A longitudinal prospective study on emotional adjustment before, during, and after consecutive fertility treatment cycles. Hum Reprod 2005; 20: 2253-60. PubMed  
  26. Zorzon M, Zivadinov R, Bosco A, et al. Sexual dysfunction and multiple sclerosis: a case-control study. I. Frequency and comparison groups. Mult Scler 1999; 5: 418-27. PubMed  
  27. Palmer BF. Sexual dysfunction in men and women with chronic kidney disease and end-stage kidney disease. Adv Ren Replace Ther 2003; 10: 48-60. PubMed  
  28. Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 2002; 94: 39-49. PubMed  
  29. Berman JR. Physiology of female sexual function and dysfunction. Int J Impot Res 2005; 17(suppl 1): S44-S51.
  30. Billups KL, Berman L, Berman J, Metz ME, Glennon ME, Goldstein I. A new non-pharmacological vacuum therapy for female sexual dysfunction. J Sex Marital Ther 2001; 27: 435-41. PubMed  
  31. Basson R, Brotto LA. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial. BJOG 2003; 110: 1014-24. PubMed  
  32. Basson R, McInnes R, Smith MD, Hodgson G, Koppiker N. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal. J Womens Health Gend Based Med 2002; 11: 367-77. PubMed  
  33. Blake J, Belisle S, Basson R, et al. Canadian Consensus Conference on Menopause 2006 update. J Obstet Gynecol Can 2006; 28: Suppl: 1-92.
  34. Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003; 348: 1839-54. New England Journal of Medicine  
  35. Wilson SK, Delk JR II, Billups KL. Treating symptoms of female sexual arousal disorder with the Eros-Clitoral Therapy Device. J Gend Specif Med 2001; 4: 54-8. PubMed  
  36. Trudel G, Marchand A, Ravart M, Aubin S, Turgeon L, Fortier P. The effect of a cognitive-behavioral group treatment program on hypoactive sexual desire in women. Sex Relat Ther 2001; 16: 145-64. PubMed  
  • Elsa Lena Ryding, docent och överläkare, Kvinnors och Barns Hälsa, Karolinska institutet

Tidigare sakkunniga

  • Terje Johannessen, professor i allmänmedicin, Institutt for samfunnsmedisinske fag, Norges teknisk-naturvitenskapelige universitet, Trondheim
  • Per Bergsjø, professor emeritus, dr. med., Universitetet i Bergen. Specialist på gynekologi och obstetrik, forskar vid Nationalt folkehelseinstitutt i Oslo